MDS

MDS Appoints New CEO, Announces Changes to Executive Team

Friday, January 8, 2010 09:50 AM

MDS has appointed chief operating officer Steve West as CEO, replacing Stephen DeFalco.

More... »

Czura Thornton to Buy MDS Central Lab Business

Monday, October 19, 2009 07:46 AM

Czura Thornton, the private investment group that already owns UK-based contract research organization (CRO) Chiltern International, has agreed to acquire the global central laboratory operations of MDS Pharma Services for about $8 million. 

More... »

Brazil Certifies MDS Pharma Services Early Clinical Facilities

Thursday, October 8, 2009 08:46 AM

MDS Pharma Services’ early clinical research and clinical pharmacology operations in Belfast, Northern Ireland, and its clinical pharmacology and bioanalytical services operation in Lincoln, Nebraska, have been certified by Brazil’s regulatory agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA).

More... »

MDS Pharma Revenues Continue to Fall, Hunt for Buyer Continues

Friday, September 11, 2009 06:42 AM

Revenues continue to fall at MDS Pharma, the contract research arm of Toronto-based MDS. Third-quarter 2009 net revenues fell 28% from the same period last year, dropping to $49 million from $68 million. The year-over-year decline was a result of decreased demand for phase I and bioanalytical services, the company said.

More... »

MDS Dumps Plan to Focus on Early-Stage, Looks to Sell Pharma Services

Thursday, September 3, 2009 05:24 AM

So much for MDS’ plans to focus its Pharma Services unit on early-stage drug development.

More... »

LabConnect Hires Former Quintiles Exec to be COO

Friday, August 28, 2009 07:32 AM

LabConnect, a provider of central laboratory services to the clinical trial industry, appointed former Quintiles executive Frank Morrow, Ph.D., as its chief operating officer.

More... »

Covance, MDS Pharma Earn MHRA Accreditation

Thursday, August 13, 2009 08:21 AM

Covance and MDS Pharma Services both recently earned standard and supplementary accreditation for the conduct of clinical pharmacology in Europe by the Medicines and Healthcare products Regulatory Agency (MHRA).

More... »

MDS Pharma Services to Expand Early-Stage Operations in Taiwan

Thursday, June 11, 2009 07:50 AM

MDS Pharma Services, the CRO division of MDS, is undertaking a major renovation and expansion of its discovery operation in Taiwan as part of the company's recently announced plan to focus on early-stage clinical research.

More... »

MDS Pharma to Focus on Early Stage, Selling Late Stage to INC Research for $50M

Monday, June 8, 2009 08:49 AM

MDS, the parent company of MDS Pharma Services, has entered into an agreement with INC Research to sell off MDS' phase II through IV contract research business for $50 million in order to focus on early-stage clinical development.

More... »

INC Research Plans to Acquire Late Stage Division of MDS for $50M

Tuesday, June 2, 2009 07:00 AM

Raleigh, N.C.-based contract research organization (CRO) INC Research entered into an agreement to acquire the phase II through IV operations of MDS Pharma Services, the clinical development division of MDS, for $50 million.

More... »